Changes of NLF in Serum of Long COVID Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05060692

Enrollment

Registered

2021-09-29

Start date

2020-06-01

Completion date

2021-11-01

Last updated

2023-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Syndrome

Brief summary

The study investigates the blood NFL levels in Long-COVID patients.

Detailed description

The study investigates the blood NFL levels in Long-COVID patients.

Interventions

DIAGNOSTIC_TESTBloot testing

NFL measruments in serum

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

Long-COVID Syndrom

Design outcomes

Primary

Measure	Time frame	Description
Levels of NFL over a 1 year course of the Long-COVID Syndrom	1 year	see above

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026